Genocea Biosciences, a biopharmaceutical company developing perso...
A team of researchers from Carnegie Mellon University, in collabo...
CyTuVax B.V.has released the results of the HBAI20 Phase 2 “BE-R...
Be The Match BioTherapies®, an organization offering solutions for...
Imcyse, a developer of active specific immunotherapies for the treatme...
WHO has launched a global campaign urging governments to adopt a tool ...
Varian has acquired Endocare® Systems, based in Austin, Texas...
Pfizer Inc. has announced positive results from ORAL Shift, a Phase 3b...
Pfizer Inc. and Array BioPharma Inc. have announced that they have ent...
GlaxoSmithKline plc has announced a five-year collaboration with the U...
Using sound vibrations and pulses of near-infrared light, a Rutgers Un...
Long-term follow-up data from the ongoing, pivotal open-label ENESTfre...
BlackThorn Therapeutics, a clinical-stage, neurobehavioral health comp...
IBM, KPMG, Merck and Walmart have announced that the companies have be...
Novo Nordisk has announced that the PIONEER 6 trial achieved its prima...
Roche has announced that Peter Voser (61), a member of the Board ...
Proximo Medical announced it has been selected by PMT Partners, a medi...
Amcor is a global leader in developing and producing responsible packa...